KAREN MOORE: Open Payments
NPI 1578012159 · LOUISA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,457 in 131 payments from 14 companies in 2025. Trend: 2023 $281 · 2024 $1,438 · 2025 $2,457
Food & beverage: $2,358Education: $99
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $812 |
| Janssen Biotech, Inc. | 18 | $462 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $230 |
| Phathom Pharmaceuticals, Inc. | 14 | $202 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 14 | $197 |
| Aimmune Therapeutics, Inc. | 8 | $190 |
| Ardelyx, Inc. | 16 | $179 |
| Madrigal Pharmaceuticals | 4 | $75 |
| Novo Nordisk Inc | 1 | $31 |
| Lilly USA, LLC | 1 | $18 |
Products named: TREMFYA, RINVOQ, ENTYVIO, VOQUEZNA, IBSRELA, QULIPTA, ZENPEP, XIFAXAN.
Industry payments across KY — which companies pay providers there.
